Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer

医学 乳腺癌 乳房切除术 放射治疗 内科学 淋巴结 临床终点 外科 腋窝 随机对照试验 肿瘤科 癌症
作者
Yong Bae Kim,Hwa Kyung Byun,Dae Yong Kim,Sung‐Ja Ahn,Hyung-Sik Lee,Won Park,Su Ssan Kim,Jin Hee Kim,Kyu Chan Lee,Ik Jae Lee,Won Taek Kim,Hyun Soo Shin,Kyubo Kim,Kyung Hwan Shin,Chung Mo Nam,Chang‐Ok Suh
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:8 (1): 96-96 被引量:32
标识
DOI:10.1001/jamaoncol.2021.6036
摘要

Importance

The benefit of internal mammary node irradiation (IMNI) for treatment outcomes in node-positive breast cancer is unknown.

Objective

To investigate whether the inclusion of IMNI in regional nodal irradiation improves disease-free survival (DFS) in women with node-positive breast cancer.

Design, Setting, and Participants

This multicenter, phase 3 randomized clinical trial was conducted from June 1, 2008, to February 29, 2020, at 13 hospitals in South Korea. Women with pathologically confirmed, node-positive breast cancer after breast-conservation surgery or mastectomy with axillary lymph node dissection were eligible and enrolled between November 19, 2008, and January 14, 2013. Patients with distant metastasis and those who had received neoadjuvant treatment were excluded. Data analyses were performed according to the intention-to-treat principle.

Interventions

All patients underwent regional nodal irradiation along with breast or chest wall irradiation. They were randomized 1:1 to receive radiotherapy either with IMNI or without IMNI.

Main Outcomes and Measures

The primary end point was the 7-year DFS. Secondary end points included the rates of overall survival, breast cancer–specific survival, and toxic effects.

Results

A total of 735 women (mean [SD] age, 49.0 [9.1] years) were included in the analyses, of whom 373 received regional nodal irradiation without IMNI and 362 received regional nodal irradiation with IMNI. Nearly all patients underwent taxane-based adjuvant systemic treatment. The median (IQR) follow-up was 100.4 (89.7-112.1) months. The 7-year DFS rates did not significantly differ between the groups treated without IMNI and with IMNI (81.9% vs 85.3%; hazard ratio [HR], 0.80; 95% CI, 0.57-1.14; log-rankP = .22). However, an ad hoc subgroup analysis showed significantly higher DFS rates with IMNI among patients with mediocentrally located tumors. In this subgroup, the 7-year DFS rates were 81.6% without IMNI vs 91.8% with IMNI (HR, 0.42; 95% CI, 0.22-0.82; log-rankP = .008), and the 7-year breast cancer mortality rates were 10.2% without IMNI vs 4.9% with IMNI (HR, 0.41; 95% CI, 0.17-0.99; log-rankP = .04). No differences were found between the 2 groups in the incidence of adverse effects, including cardiac toxic effects and radiation pneumonitis.

Conclusions and Relevance

This randomized clinical trial found that including IMNI in regional nodal irradiation did not significantly improve the DFS in patients with node-positive breast cancer. However, patients with medially or centrally located tumors may benefit from the use of IMNI.

Trial Registration

ClinicalTrials.gov Identifier:NCT04803266
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
养乐多完成签到,获得积分10
刚刚
Ada发布了新的文献求助10
1秒前
小猪猪完成签到 ,获得积分10
1秒前
悄悄是心上的肖肖完成签到 ,获得积分10
2秒前
西贝完成签到,获得积分10
2秒前
柯忻完成签到,获得积分10
2秒前
Hhhh完成签到 ,获得积分10
2秒前
尧尧完成签到,获得积分20
3秒前
sswbzh应助Hardendotey采纳,获得50
3秒前
3秒前
3秒前
4秒前
5秒前
闹闹完成签到 ,获得积分10
5秒前
jiajia发布了新的文献求助10
7秒前
羽羽完成签到 ,获得积分10
7秒前
科研通AI2S应助zxy采纳,获得10
7秒前
9秒前
9秒前
爱学习的小花生完成签到,获得积分10
10秒前
苗喵喵87完成签到,获得积分10
10秒前
Veee发布了新的文献求助10
10秒前
10秒前
小lai发布了新的文献求助10
10秒前
12秒前
小张今晚有好梦-完成签到 ,获得积分10
12秒前
Ada完成签到 ,获得积分10
13秒前
江南烟雨如笙完成签到 ,获得积分10
14秒前
14秒前
sharing发布了新的文献求助10
15秒前
15秒前
coldspringhao完成签到,获得积分10
15秒前
11111发布了新的文献求助10
16秒前
张张完成签到,获得积分10
16秒前
圆脸妹妹完成签到,获得积分20
16秒前
宓鲂完成签到,获得积分10
16秒前
jagger完成签到,获得积分10
17秒前
含蓄含烟完成签到,获得积分10
17秒前
GGbond应助文龙采纳,获得10
18秒前
麦田稻草人完成签到,获得积分10
18秒前
高分求助中
Heun’s Differential Equations 600
《Fundamentals of Power Supply Design》Robert A. Mammano 510
谁能看见前面有梦可想 500
High Wire: How China Regulates Big Tech and Governs Its Economy 260
lingnan science journal vol. 16 250
The philosophy of sports medicine care: an historical review 250
A posteriori勾配制限手法「ポストリミタ」と界面捕獲法THINCを組み合わせた連続・不連続流れを高解像するMUSCLタイプの解法 210
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2249568
求助须知:如何正确求助?哪些是违规求助? 1898637
关于积分的说明 4736112
捐赠科研通 1688193
什么是DOI,文献DOI怎么找? 856321
版权声明 545291
科研通“疑难数据库(出版商)”最低求助积分说明 453242